Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

God’s Covenant Still Stands: Debunking Replacement Theology

God’s Covenant Stands: Why Replacement Theology Gets It Wrong By…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Unlocking Daniel 8: From Ancient Kingdoms to the Antichrist

Daniel 8 Unlocked: Prophetic Clarity for the Endtime Generation By…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Daniel 8: The Vision That Shook a Prophet—and Foretells Our Future

A Ram, a Goat, and the Rise of Global Power—Decoded Through…
Read more